Literature DB >> 10069601

Long-term remission of malignant brain tumors after intracranial infection: a report of four cases.

A P Bowles1, E Perkins.   

Abstract

OBJECTIVE: This report describes four patients with malignant brain tumors in whom regression or cure seems to be related to infection with bacteria.
METHODS: An analysis of the four clinical cases reported and a review of the literature produced a comprehensive body of both experimental and clinical data concerning the antineoplastic properties of bacteria.
RESULTS: Although direct oncolytic effects from bacteria have been suggested, immune adjuvant responses to tumor suppression are emphasized. In one of our patients, infiltration of numerous granulocytes and lymphocytes into the tumor at the time of initial surgery was observed, suggesting that a spontaneous immune reaction had begun. Also, in two other patients, tumor aggression occurred in association with a bacterial process that was not in direct contact with the tumor. In three of the cases described, Enterobacter aerogenes was recovered from the microbial cultures. Whether the presence of this organism was coincidental or whether this organism plays an important role in tumor defense is not known; however, a specific cross-reactive immunological attack to the tumor is suggested.
CONCLUSION: The case histories presented in conjunction with the relevant literature reviewed support the concept that microbial infections may influence immune responses in brain tumor defense.

Entities:  

Mesh:

Year:  1999        PMID: 10069601     DOI: 10.1097/00006123-199903000-00110

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  22 in total

1.  CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.

Authors:  Isaac Yang; Tarik Tihan; Seunggu J Han; Margaret R Wrensch; John Wiencke; Michael E Sughrue; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2010-08-19       Impact factor: 1.961

Review 2.  TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme-Future Perspectives.

Authors:  Jakub Litak; Cezary Grochowski; Joanna Litak; Ida Osuchowska; Krzysztof Gosik; Elżbieta Radzikowska; Piotr Kamieniak; Jacek Rolinski
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

3.  Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report.

Authors:  Daniela A Bota; Daniela Alexandru-Abrams; Chrystel Pretto; Florence M Hofman; Thomas C Chen; Beverly Fu; Jose A Carrillo; Virgil Ejc Schijns; Apostolos Stathopoulos
Journal:  Perm J       Date:  2015-03-01

4.  WHO grade I meningiomas: classification-tree for prognostic factors of survival.

Authors:  Jean-Michel Lemée; Holger Joswig; Michele Da Broi; Marco Vincenzo Corniola; David Scheie; Karl Schaller; Eirik Helseth; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2019-06-10       Impact factor: 3.042

5.  Surgical Site Infections after glioblastoma surgery: results of a multicentric retrospective study.

Authors:  Henri Salle; Elise Deluche; Elodie Couvé-Deacon; Anne-Claire Beaujeux; Johan Pallud; Alexandre Roux; Arnaud Dagain; Amaury de Barros; Jimmy Voirin; Romuald Seizeur; Houda Belmabrouk; Leslie Lemnos; Evelyne Emery; Marie-Jeanne Fotso; Julien Engelhardt; Vincent Jecko; Ilyess Zemmoura; Tuan Le Van; Moncef Berhouma; Hélène Cebula; Matthieu Peyre; Pierre-Marie Preux; François Caire
Journal:  Infection       Date:  2020-10-09       Impact factor: 3.553

Review 6.  Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.

Authors:  James F Curtin; Gwendalyn D King; Marianela Candolfi; Remy B Greeno; Kurt M Kroeger; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

7.  Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival.

Authors:  Mariana Brutschin Pereira; Luciana Rodrigues Carvalho Barros; Paula A Bracco; Alvaro Vigo; Mariana Boroni; Martín Hernán Bonamino; Guido Lenz
Journal:  Oncoimmunology       Date:  2018-02-12       Impact factor: 8.110

8.  Spontaneous regression of colorectal liver metastasis.

Authors:  Ryota Matsuki; Masanori Sugiyama; Shinya Yoshiike; Junji Shibahara; Masaharu Kogure; Masaaki Yokoyama; Yutaka Suzuki; Nobutsugu Abe; Tadahiko Masaki; Toshiyuki Mori
Journal:  Clin J Gastroenterol       Date:  2018-03-15

9.  Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.

Authors:  Yaoqing Shen; Cameron J Grisdale; Sumaiya A Islam; Pinaki Bose; Jake Lever; Eric Y Zhao; Natalie Grinshtein; Yussanne Ma; Andrew J Mungall; Richard A Moore; Xueqing Lun; Donna L Senger; Stephen M Robbins; Alice Yijun Wang; Julia L MacIsaac; Michael S Kobor; H Artee Luchman; Samuel Weiss; Jennifer A Chan; Michael D Blough; David R Kaplan; J Gregory Cairncross; Marco A Marra; Steven J M Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-30       Impact factor: 11.205

10.  Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas.

Authors:  Christopher L Mariani; Didier Rajon; Francis J Bova; Wolfgang J Streit
Journal:  J Neurooncol       Date:  2007-06-14       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.